Short-Term Consequences of Angiographically-Confirmed Coronary Stent Thrombosis

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Kohn, Christine G ^a,b   Kluger, Jeffrey ^b   Azeem, Meena ^b   Coleman, Craig I ^a,b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ARTERIOGRAPHY; ARTICLE; BARE METAL STENT; CORONARY STENT; COST OF ILLNESS; DEATH; DRUG ELUTING STENT; HEART CATHETERIZATION; HEART INFARCTION; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LENGTH OF STAY; META ANALYSIS; MORTALITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); STENT THROMBOSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; HUMANS; STENTS; TIME FACTORS;

EID: 84885448268     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077330     Document Type: Article

References (32)

1. Auerbach D, Maeda J, Steiner C, (2012) Hospital Stays with Cardiac Stents, 2009. HCUP Statistical Brief 128. Rockville, MD: Agency for Healthcare Research and Quality. Available: http://www.hcup-us.ahrq.gov/reports/ statbriefs/sb128.pdf. (Accessed December 8, 2012).
2. Honda Y, Fitzgerald PJ, (2003) Stent thrombosis: an issue revisited in a changing world. Circulation 108: 2-5. doi:10.1161/01.CIR.0000075929.79964.D8. PubMed: 12847051.
3. Cutlip DE, Baim DS, Ho KK, Popma JJ, Lansky AJ, et al. (2001) Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 103: 1967-1971. doi:10.1161/01.CIR.103.15.1967. PubMed: 11306525.
4. Reynolds MR, Rinaldi MJ, Pinto DS, Cohen DJ, (2002) Current clinical characteristics and economic impact of subacute stent thrombosis. J Invasive Cardiol 14: 364-368. PubMed: 12082187.
5. Moher D, Liberati A, Tetzlaff J, Altman DG, the PRISMA Group (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLOS Med 6: e1000097. doi:10.1371/journal.pmed1000097.
6. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, et al. (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115: 2344-2351. doi:10.1161/CIRCULATIONAHA.106.685313. PubMed: 17470709.
7. Armstrong EJ, Feldman DN, Wang TY, Kaltenbach LA, Yeo KK, et al. (2012) Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis. JACC Cardiovasc Intv 5: 131-140. doi:10.1016/j.jcmg.2011.11.011. PubMed: 22361596.
8. Becker D, Maurovich-Horvat P, Barczi G, Szabó G, Fülöp G, et al. (2009) Life after coronary stent thrombosis. Med Sci Monit 15: CR236-41. PubMed: 19396039.
9. Burzotta F, Parma A, Pristipino C, Manzoli A, Belloni F, et al. (2008) Angiographic and clinical outcome of invasively managed patients with thrombosed coronary bare metal or drug-eluting stents: the OPTIMIST study. Eur Heart J 29: 3011-3021. doi:10.1093/eurheartj/ehn479. PubMed: 18987096.
10. Chechi T, Vecchio S, Vittori G, Giuliani G, Lilli A, et al. (2008) ST-segment elevation myocardial infarction due to early and late stent thrombosis a new group of high-risk patients. J Am Coll Cardiol 51: 2396-2402. doi:10.1016/j.jacc.2008.01.070. PubMed: 18565395.
11. Cheneau E, Leborgne L, Mintz GS, Kotani J, Pichard AD, et al. (2003) Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study. Circulation 108: 43-47. doi:10.1161/01.CIR.0000084513.38337.CB. PubMed: 12821553.
12. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, et al. (2007) Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369: 667-678. doi:10.1016/S0140-6736(07)60314-6. PubMed: 17321312.
13. Danenberg HD, Marincheva G, Varshitzki B, Nassar H, Lotan C, (2009) Stent thrombosis: a poor man's disease? Isr Med Assoc J 11: 529-532. PubMed: 19960845.
14. de la Torre-Hernández JM, Alfonso F, Hernández F, Elizaga J, Sanmartin M, et al. (2008) Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos). J Am Coll Cardiol 51: 986-990. doi:10.1016/j.jacc.2007.10.057. PubMed: 18325436.
15. Del Pace S, Boddi M, Rasoini R, Micheli S, Alderighi C, et al. (2010) Acute infection-inflammation and coronary stent thrombosis: an observational study. Intern. Emerg Med 5: 121-126.
16. Ergelen M, Gorgulu S, Uyarel H, Norgaz T, Aksu H, et al. (2010) The outcome of primary percutaneous coronary intervention for stent thrombosis causing ST-elevation myocardial infarction. Am Heart J 159: 672-676. doi:10.1016/j.ahj.2009.12.032. PubMed: 20362728.
17. Heestermans AA, van Werkum JW, Zwart B, van der Heyden JA, Kelder JC, et al. (2010) Acute and subacute stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: incidence, predictors and clinical outcome. J Thromb Haemost 8: 2385-2393. doi:10.1111/j.1538-7836.2010.04046.x. PubMed: 20831622.
18. Kimura T, Morimoto T, Kozuma K, Honda Y, RESTART Investigators et al. (2010) Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: Observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART). Circulation 122: 52-61. doi:10.1161/CIRCULATIONAHA.109.903955. PubMed: 20566955.
19. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, et al. (2006) Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 113: 1108-1113. doi:10.1161/CIRCULATIONAHA.105.600155. PubMed: 16490815.
20. Le Feuvre C, Helft G, Cohen S, Batisse JP, Barthélémy O, et al. (2008) Characteristics and prognosis of patients with angiographic stent thrombosis: comparison between drug-eluting and bare-metal stents. Arch. Cardiovasc Dis 101: 220-225. doi:10.1016/S1875-2136(08)73696-9.
21. Lee CW, Kang SJ, Park DW, Lee SH, Kim YH, et al. (2010) Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation. J Am Coll Cardiol 55: 1936-1942. doi:10.1016/j.jacc.2009.10.077. PubMed: 20430265.
22. Lemesle G, de Labriolle A, Bonello L, Pinto Slottow TL, Torguson R, et al. (2009) Impact of thrombus aspiration use for the treatment of stent thrombosis on early patient outcomes. J Invasive Cardiol 21: 210-214. PubMed: 19411720.
23. Mahmoud KD, Vlaar PJ, van den Heuvel AF, Hillege HL, Zijlstra F, et al. (2011) Usefulness of thrombus aspiration for the treatment of coronary stent thrombosis. Am J Cardiol 108: 1721-1727. doi:10.1016/j.amjcard.2011.07.044. PubMed: 21906707.
24. Pinto Slottow TL, Steinberg DH, Roy PK, Buch AN, Okabe T, Xet al (2008) Observations and outcomes of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period. Am J Cardiol 102: 298-303 doi:10.1016/j.amjcard.2008.03.055. PubMed: 18638590.
25. van Werkum JW, Heestermans AA, de Korte FI, Kelder JC, Suttorp MJ, et al. (2009) Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases. Circulation 119: 828-834. doi:10.1161/CIRCULATIONAHA.108.799403. PubMed: 19188507.
26. Wenaweser P, Daemen J, Zwahlen M, van Domburg R, Jüni P, et al. (2008) Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol 52: 1134-1140. doi:10.1016/j.jacc.2008.07.006. PubMed: 18804739.
27. Wenaweser P, Rey C, Eberli FR, Togni M, Tüller D, et al. (2005) Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome. Eur Heart J 26: 1180-1187. doi:10.1093/eurheartj/ehi135. PubMed: 15728650.
28. Yeo KK, Mahmud E, Armstrong EJ, Bennett WE, Shunk KA, et al. (2012) Contemporary clinical characteristics, treatment, and outcomes of angiographically confirmed coronary stent thrombosis: results from a multicenter California registry. Catheter Cardiovasc Interv 79: 550-556. doi:10.1002/ccd.23011. PubMed: 21563289.
29. Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, et al. (2009) Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation 119: 3198-3206. doi:10.1161/CIRCULATIONAHA.108.826479. PubMed: 19528338.
30. Brar SS, Leon MB, Stone GW, Mehran R, Moses JW, et al. (2009) Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis. J Am Coll Cardiol 18: 1677-1689. PubMed: 19406344.
31. Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, for the j-Cypher Registry Investigatorset al (2009) Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation 119: 987-995. doi:10.1161/CIRCULATIONAHA.108.808311. PubMed: 19204304.
32. Windecker S, Meier B, (2007) Late coronary stent thrombosis. Circulation 116: 1952-1965. doi:10.1161/CIRCULATIONAHA.106.683995. PubMed: 17965406.